Late-Stage Pharmaceutical R&D and Pricing Policies Under Two-Stage Regulation

Journal of Health Economics - Netherlands
doi 10.1016/j.jhealeco.2016.06.002
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

European Pharmaceutical Price Regulation, Firm Profitability, and R&D Spending

SSRN Electronic Journal
2006English

Two-Stage Robust Network Flow and Design Under Demand Uncertainty

Operations Research
Management ScienceComputer Science ApplicationsOperations Research
2007English

Food Behavior Change in Late-Life Widowhood: A Two-Stage Process

Appetite
NutritionPsychologyDietetics
2015English

Two-Stage Ordering Policy Under Buyer’s Minimum-Commitment Quantity Contract

American Journal of Operations Research
2011English

When Do Two-Stage Processes Outperform One-Stage Processes?

Biotechnology Journal
Applied MicrobiologyBiotechnologyMolecular MedicineMedicine
2017English

Late-Stage Diversification of Natural Products

ACS Central Science
ChemistryChemical Engineering
2020English

Big Data in Pharmaceutical R&D: Creating a Sustainable R&D Engine

Pharmaceutical Medicine
Pharmacology
2015English

Applications of Two-Part Pricing in Pharmaceutical Markets

Health Affairs
MedicineHealth Policy
2008English

Informational Size and Two-Stage Mechanisms

SSRN Electronic Journal
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy